1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Dan Cunningham

Discussion in 'Dermira' started by anonymous, Oct 24, 2018 at 3:31 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What's his deal....good guy or total douchebag, dickhead?
     

  2. anonymous

    anonymous Guest

    Dan is awesome will always trust you and never micromanage. I’m honestly surprised someone would even ask that about him. Nothing but good things and have never heard anyone say otherwise.
     
  3. anonymous

    anonymous Guest

    Thanks Dan